Olema Pharmaceuticals (OLMA) Equity Ratio (2020 - 2026)
Olema Pharmaceuticals (OLMA) has 7 years of Equity Ratio data on record, last reported at 0.91 in Q1 2026.
- On a quarterly basis, Equity Ratio fell 3.27% to 0.91 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.91, a 3.27% decrease, with the full-year FY2025 number at 0.9, down 1.07% from a year prior.
- Equity Ratio reached 0.91 in Q1 2026 per OLMA's latest filing, up from 0.9 in the prior quarter.
- Over the last five years, Equity Ratio for OLMA hit a ceiling of 0.96 in Q1 2022 and a floor of 0.86 in Q3 2024.
- A 5-year average of 0.91 and a median of 0.91 in 2024 define the central range for Equity Ratio.
- Peak YoY movement for Equity Ratio: dropped 8.03% in 2024, then increased 4.45% in 2025.
- Tracing OLMA's Equity Ratio over 5 years: stood at 0.92 in 2022, then increased by 0.08% to 0.92 in 2023, then fell by 1.08% to 0.91 in 2024, then decreased by 1.07% to 0.9 in 2025, then grew by 0.93% to 0.91 in 2026.
- Business Quant data shows Equity Ratio for OLMA at 0.91 in Q1 2026, 0.9 in Q4 2025, and 0.87 in Q3 2025.